Vivani Medical (VANI) Cash & Equivalents (2014 - 2026)

Vivani Medical's Cash & Equivalents history runs 13 years deep, the most recent figure standing at $19.7 million for Q1 2026.

• In Q1 2026, Cash & Equivalents rose 51.82% year-over-year to $19.7 million; the TTM figure through Mar 2026 stood at $19.7 million (up 51.82% YoY), while the FY2025 annual figure was $16.2 million, down 11.55% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $19.7 million, up from $16.2 million in the prior quarter.
• The five-year high for Cash & Equivalents was $59.6 million in Q1 2022, with the low at $1.3 million in Q4 2023.
• The 5-year median for Cash & Equivalents is $24.8 million (2023), against an average of $27.1 million.
• The sharpest annual moves came in 2022 and 2023: Cash & Equivalents surged 4294.9% in 2022, then sank 97.12% in 2023.
• Vivani Medical's Cash & Equivalents stood at $45.1 million in 2022, then tumbled by 97.12% to $1.3 million in 2023, then surged by 1311.69% to $18.4 million in 2024, then slipped by 11.55% to $16.2 million in 2025, then advanced by 21.67% to $19.7 million in 2026.
• Business Quant data shows VANI's Cash & Equivalents at $19.7 million in Q1 2026, $16.2 million in Q4 2025, and $2.6 million in Q3 2025.